| ||
| New Pill For Rheumatoid Arthritis Gets FDA Nod Alabama Public Radio He figures a year of treatment with Xeljanz would run only $2,000 or so less than treatment with Enbrel or Humira. Xeljanz is for patients with moderate-to-severe rheumatoid arthritis who either can't tolerate or don't respond to methotrexate, the Food ... See all stories on this topic » |
This as-it-happens Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment